Update shared on28 Sep 2025
Fair value Increased 3.98%Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment.
Analyst Commentary
- Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.
- Increased confidence in margin expansion, supported by lower costs and improved product mix.
- Strong execution on pricing strategies, procurement, and portfolio repositioning.
- Successful implementation of manufacturing optimization initiatives.
- Outperformance attributed to effective management navigating a challenging macro backdrop.
What's in the News
- Fiscal 2025 net revenue guidance lowered; expected to decline 2% to 3%, with organic revenue projected to be flat to up 1% and a 1% adverse foreign exchange impact.
- Removed from Russell Small Cap Comp Growth, Russell 2000 Growth, Russell 3000E Growth, Russell 3000 Growth, and Russell 2500 Growth benchmarks.
Valuation Changes
Summary of Valuation Changes for H.B. Fuller
- The Consensus Analyst Price Target has risen slightly from $66.20 to $68.83.
- The Future P/E for H.B. Fuller has risen from 14.70x to 15.94x.
- The Net Profit Margin for H.B. Fuller has fallen slightly from 7.93% to 7.64%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.